ERBE Elektromedizin GmbH, headquartered in Tübingen, Germany, is a leading innovator in the medical technology industry, specialising in high-frequency surgical equipment and devices. Founded in 1851, the company has established a strong presence in Europe and beyond, focusing on areas such as electrosurgery, laser therapy, and endoscopy. With a commitment to advancing surgical techniques, ERBE offers a range of core products, including the renowned VIO® electrosurgical generator and the ICC® plasma coagulation system, which are distinguished by their precision and reliability. The company has achieved significant milestones, including numerous patents and awards, solidifying its position as a trusted partner in healthcare. ERBE Elektromedizin continues to lead the market with innovative solutions that enhance surgical outcomes and improve patient safety.
How does ERBE Elektromedizin GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ERBE Elektromedizin GmbH's score of 20 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ERBE Elektromedizin GmbH, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that ERBE Elektromedizin may not have publicly committed to specific climate initiatives or reduction strategies at this time. In the context of the industry, many companies are increasingly focusing on sustainability and carbon footprint reduction, often setting science-based targets to align with global climate goals. However, without specific commitments or emissions data, it is unclear how ERBE Elektromedizin is addressing climate change within its operations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ERBE Elektromedizin GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
